Dr Reddys Stock Future Price Prediction

RDY
 Stock
  

USD 53.46  0.55  1.04%   

Dr Reddys Laboratories stock price prediction is an act of determining the future value of Dr Reddys shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Dr Reddys' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Dr Reddys and does not consider all of the tangible or intangible factors available from Dr Reddys' fundamental data. We analyze noise-free headlines and recent hype associated with Dr Reddys Laboratories, which may create opportunities for some arbitrage if properly timed.
Additionally, take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Dr Reddys based on different types of headlines from major news networks to social media. The Dr Reddys stock price prediction module provides an analysis of price elasticity to changes in media outlook on Dr Reddys over a specific investment horizon.
Quarterly Earnings Growth YOY
1.08
EPS Estimate Current Year
2.35
EPS Estimate Next Year
2.5
Wall Street Target Price
63.67
Quarterly Revenue Growth YOY
0.06
Using Dr Reddys hype-based prediction, you can estimate the value of Dr Reddys Laboratories from the perspective of Dr Reddys response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Dr Reddys using Dr Reddys' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Dr Reddys using crowd psychology based on the activity and movement of Dr Reddys' stock price.

Dr Reddys Short Interest

A significant increase or decrease in Dr Reddys' short interest from the previous month could be a good indicator of investor sentiment towards Dr Reddys. Short interest can provide insight into the potential direction of Dr Reddys stock and how bullish or bearish investors feel about the market overall. An investor who is long Dr Reddys may also wish to track short interest. As short interest increases, investors should be becoming more worried about Dr Reddys and may potentially protect profits, hedge Dr Reddys with its derivative instruments, or be ready for some potential downside.
200 Day MA
57.12
Short Percent
0.0083
Short Ratio
6.16
Shares Short Prior Month
1.8 M
50 Day MA
54.8
Shares Short
1.3 M
Beta
0.23

Dr Reddys Laboratories Hype to Price Pattern

Investor biases related to Dr Reddys' public news can be used to forecast risks associated with investment in Dr Reddys. The trend in average sentiment can be used to explain how an investor holding Dr Reddys can time the market purely based on public headlines and social activities around Dr Reddys Laboratories. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Dr Reddys' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Dr Reddys.

Dr Reddys Implied Volatility

    
  26.01  
Dr Reddys' implied volatility exposes the market's sentiment of Dr Reddys Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Dr Reddys' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Dr Reddys stock will not fluctuate a lot when Dr Reddys' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Dr Reddys. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Dr Reddys to buy its stock at a price that has no basis in reality. In that case, they are not buying Dr Reddys because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Dr Reddys after-hype prediction price

    
  $ 53.33  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dr Reddys in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
49.3151.0958.78
Details
Naive
Forecast
LowNext ValueHigh
52.8054.5856.36
Details
2 Analysts
Consensus
LowTarget PriceHigh
41.9048.9556.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
1.251.261.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dr Reddys. Your research has to be compared to or analyzed against Dr Reddys' peers to derive any actionable benefits. When done correctly, Dr Reddys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Dr Reddys Laboratories.

Dr Reddys After-Hype Price Prediction Density Analysis

As far as predicting the price of Dr Reddys at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dr Reddys or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Dr Reddys, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Dr Reddys Estimiated After-Hype Price Volatility

In the context of predicting Dr Reddys' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dr Reddys' historical news coverage. Dr Reddys' after-hype downside and upside margins for the prediction period are 51.55 and 55.11, respectively. We have considered Dr Reddys' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 53.46
53.33
After-hype Price
55.11
Upside
Dr Reddys is very steady asset. Analysis and calculation of next after-hype price of Dr Reddys Laboratories is based on 3 months time horizon.

Dr Reddys Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Dr Reddys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dr Reddys backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dr Reddys, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.14  1.78   0.11   0.10  7 Events / Month8 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
53.4653.330.21 
222.50  

Dr Reddys Hype Timeline

On the 10th of August Dr Reddys Laboratories is traded for 53.46. The entity has historical hype elasticity of -0.11 and average elasticity to hype of competition of 0.1. Dr Reddys is forecasted to decline in value after the next headline with price expected to drop to 53.33. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price depreciation on the next newsis expected to be -0.21% whereas the daily expected return is at this time at 0.14%. The volatility of related hype on Dr Reddys is about 255.5% with expected price after next announcement by competition of 53.56. The company has price-to-book ratio of 0.04. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Dr Reddys Laboratories has Price/Earnings To Growth (PEG) ratio of 0.68. The entity next dividend is scheduled to be issued on the 8th of July 2021. The firm had 2:1 split on the 7th of September 2006. Considering the 90-day investment horizon the next forecastedpress releasewill be in about 7 days.
Additionally, take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections.

Dr Reddys Related Hype Analysis

Having access to credible news sources related to Dr Reddys' direct competition is more important than ever and may enhance your ability to predict Dr Reddys' future price movements. Getting to know how Dr Reddys rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dr Reddys may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
REGNRegeneron Pharmaceuticals 15.99 11 per month 0.00 (0.0084)  3.41 (3.94)  8.72 
PFEPfizer Inc 0.24 9 per month 1.62  0.05  2.93 (2.35)  7.74 
FFIEFaraday Future Intelligent(0.02) 5 per month 10.36  0.07  21.18 (16.25)  75.24 
HDHome Depot(3.85) 9 per month 1.90  0.0334  2.39 (2.82)  7.62 
DDDupont Denemours 0.38 10 per month 0.00 (0.07)  3.03 (3.21)  9.48 
IBMInternational Business Machines(3.78) 6 per month 0.00 (0.014)  2.09 (2.48)  7.86 
JPMJP Morgan Chase(2.70) 6 per month 0.00 (0.0408)  3.03 (2.43)  10.79 
BABoeing Company(0.63) 8 per month 3.06  0.06  6.45 (5.03)  16.31 
JNJJohnson Johnson 0.64 7 per month 0.00 (0.0381)  1.75 (1.86)  5.07 

Dr Reddys Additional Predictive Modules

Most predictive techniques to examine Dr Reddys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dr Reddys using various technical indicators. When you analyze Dr Reddys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Dr Reddys Predictive Indicators

The successful prediction of Dr Reddys stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dr Reddys Laboratories, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dr Reddys based on analysis of Dr Reddys hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dr Reddys's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dr Reddys's related companies.

Story Coverage note for Dr Reddys

The number of cover stories for Dr Reddys depends on current market conditions and Dr Reddys' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dr Reddys is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dr Reddys' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Dr Reddys Short Properties

Dr Reddys' future price predictability will typically decrease when Dr Reddys' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dr Reddys Laboratories often depends not only on the future outlook of the potential Dr Reddys' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dr Reddys' indicators that are reflective of the short sentiment are summarized in the table below.
Last Dividend Date1st of August 2022
Shares Percent Shares Out0.78%
Trailing Annual Dividend Rate30.00
Float Shares116.91M
Average Daily Volume Last 10 Day187.74k
Shares Short Prior Month1.77M
Average Daily Volume In Three Month201.65k
Date Short Interest15th of July 2022
Trailing Annual Dividend Yield56.42%
Additionally, take a look at Dr Reddys Basic Forecasting Models to cross-verify your projections. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know Dr Reddys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.08
Market Capitalization
8.8 B
Quarterly Revenue Growth YOY
0.06
Return On Assets
0.0781
Return On Equity
0.16
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of Dr Reddys that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine Dr Reddys value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.